107 related articles for article (PubMed ID: 7798669)
41. Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma.
Seymour JF; Talpaz M; Cabanillas F; Wetzler M; Kurzrock R
J Clin Oncol; 1995 Mar; 13(3):575-82. PubMed ID: 7884418
[TBL] [Abstract][Full Text] [Related]
42. Circulating levels of thrombopoietic and inflammatory cytokines in patients with acute myeloblastic leukemia and myelodysplastic syndrome.
Hsu HC; Lee YM; Tsai WH; Jiang ML; Ho CH; Ho CK; Wang SY
Oncology; 2002; 63(1):64-9. PubMed ID: 12187073
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of natural killer cells as diagnostic markers of early onset neonatal sepsis: comparison with C-reactive protein and interleukin-8.
el-Sameea ER; Metwally SS; Mashhour E; el-Bendary A; Hassan AM; el-Sharkawy H; el-Shennawy FA
Egypt J Immunol; 2004; 11(1):91-102. PubMed ID: 15724391
[TBL] [Abstract][Full Text] [Related]
44. Incidence and clinical significance of positive blood cultures in febrile episodes of patients with hematological malignancies.
Rintala E
Scand J Infect Dis; 1994; 26(1):77-84. PubMed ID: 8191244
[TBL] [Abstract][Full Text] [Related]
45. Cord blood levels of interleukin-6 and interleukin-8 for the immediate diagnosis of early-onset infection in premature infants.
Krueger M; Nauck MS; Sang S; Hentschel R; Wieland H; Berner R
Biol Neonate; 2001 Aug; 80(2):118-23. PubMed ID: 11509811
[TBL] [Abstract][Full Text] [Related]
46. Use of ceftazidime in febrile incidents in immunocompromised haematological patients.
d'Oliveira JJ; Pereira ME; Mateus LM; Monteiro JM; Parreira AS; Soares AD
J Int Med Res; 1986; 14(1):30-4. PubMed ID: 3514313
[TBL] [Abstract][Full Text] [Related]
47. [Incidence, prognosis and prevention of septicaemias in patients under treatment for acute leukaemia (author's transl)].
Gastaut JA; Maraninchi D; Bagarry Liegey D; Lejeune C; Novakovitch G; Sebahoun G; Meyer G; Carcassonne Y
Nouv Presse Med; 1982 Feb; 11(8):579-82. PubMed ID: 7070992
[TBL] [Abstract][Full Text] [Related]
48. [Leukocyte transfusion in post-chemotherapy agranulocytosis observed in malignant blood diseases].
Goudemand M; Delmas-Marsalet Y; Bauters F
Lille Med; 1968 Mar; 13(3):313-21. PubMed ID: 5759508
[No Abstract] [Full Text] [Related]
49. Fever in acute myelogenous leukemia.
Goodall PT; Vosti KL
Arch Intern Med; 1975 Sep; 135(9):1197-203. PubMed ID: 1057870
[TBL] [Abstract][Full Text] [Related]
50. Anti-inflammatory cytokine profile and mortality in febrile patients.
van Dissel JT; van Langevelde P; Westendorp RG; Kwappenberg K; Frölich M
Lancet; 1998 Mar; 351(9107):950-3. PubMed ID: 9734942
[TBL] [Abstract][Full Text] [Related]
51. Biomarkers for bacteremia and severe sepsis in hematological patients with neutropenic fever: multivariate logistic regression analysis and factor analysis.
Juutilainen A; Hämäläinen S; Pulkki K; Kuittinen T; Nousiainen T; Jantunen E; Koivula I
Leuk Lymphoma; 2011 Dec; 52(12):2349-55. PubMed ID: 21756036
[TBL] [Abstract][Full Text] [Related]
52. Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer.
Kitanovski L; Jazbec J; Hojker S; Gubina M; Derganc M
Eur J Clin Microbiol Infect Dis; 2006 Jun; 25(6):413-5. PubMed ID: 16767494
[No Abstract] [Full Text] [Related]
53. Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients.
Oude Nijhuis CSM; Vellenga E; Daenen SMGJ; van der Graaf WTA; Gietema JA; Groen HJM; Kamps WA; de Bont ESJM
Intensive Care Med; 2003 Dec; 29(12):2157-2161. PubMed ID: 14569424
[TBL] [Abstract][Full Text] [Related]
54. [Empirical antibiotic therapy in febrile neutropenic patients with acute leukemia].
Yabe H; Nakamura F; Ishikawa T; Nagai K; Nakayama S
Rinsho Ketsueki; 1989 May; 30(5):644-9. PubMed ID: 2795878
[TBL] [Abstract][Full Text] [Related]
55. [Empirical antimicrobial therapy of infection and fever episodes in children and adolescents with neutropenia caused by cytotoxic chemotherapy].
Fink FM; Frischhut-Schiffer EM; Ausserer B; Allerberger F; Guggenbichler JP
Padiatr Padol; 1989; 24(1):33-42. PubMed ID: 2717190
[TBL] [Abstract][Full Text] [Related]
56. Low-dose amphotericin B lipid complex for the treatment of persistent fever of unknown origin in patients with hematologic malignancies and prolonged neutropenia.
Martino R; Subirá M; Domingo-Albós A; Sureda A; Brunet S; Sierra J
Chemotherapy; 1999; 45(3):205-12. PubMed ID: 10224343
[TBL] [Abstract][Full Text] [Related]
57. IL-6, MMP 3 and prognosis in previously healthy sepsis patients.
Ricarte-Bratti JP; Brizuela NY; Jaime-Albarran N; Montrull HL
Rev Fac Cien Med Univ Nac Cordoba; 2017; 74(2):99-106. PubMed ID: 28657528
[TBL] [Abstract][Full Text] [Related]
58. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia.
Lehrnbecher T; Venzon D; de Haas M; Chanock SJ; Kühl J
Clin Infect Dis; 1999 Aug; 29(2):414-9. PubMed ID: 10476751
[TBL] [Abstract][Full Text] [Related]
59. Cefepime monotherapy for the empirical treatment of fever in granulocytopenic cancer patients.
Eggimann P; Glauser MP; Aoun M; Meunier F; Calandra T
J Antimicrob Chemother; 1993 Nov; 32 Suppl B():151-63. PubMed ID: 8150759
[TBL] [Abstract][Full Text] [Related]
60. Microbial translocation contribute to febrile episodes in adults with chemotherapy-induced neutropenia.
Wong M; Barqasho B; Ohrmalm L; Tolfvenstam T; Nowak P
PLoS One; 2013; 8(7):e68056. PubMed ID: 23874493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
